The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Treatment of fibromyalgia syndrome with gabapentin and pregabalin – A meta-analysis of randomized controlled trials
Abstract
The efficacy of gabapentin (GPT) and pregabalin (PGB) in the treatment of fibromyalgia syndrome (FMS) was assessed. We screened MEDLINE, PsycINFO, SCOPUS, www.clinicaltrials.org, the Cochrane Library (through October 2008), and the reference sections of original studies on GPT/PGB in FMS. Randomized controlled trials (RCTs) on the treatment of FMS with GPT and PGB were analyzed. Six out of 127 RCTs studying 2422 subjects on treatment with GPT (one study) or PGB (five studies) and 1056 subjects on placebo with a median treatment duration of 11 weeks were included into the systematic review. Five studies were suitable for meta-analysis. Effects were summarized using standardized mean differences (SMD). There was strong evidence for a reduction of pain (SMD -0.28, 95% CI -0.36, -0.20; p<0.001), improved sleep (SMD -0.39, 95% CI -0.48, -0.39; p<0.001), and improved health-related quality of life (HRQOL) (SMD -0.30, 95% CI -0.46, -0.15; p<0.001), but not for depressed mood (SMD -0.12, 95% CI -0.30, 0.06; p=0.18). There was strong evidence for a non-substantial reduction of fatigue (SMD -0.16, 95% CI -0.23, -0.09, p<0.001) and of anxiety (SMD -0.18, 95% CI -0.27, -0.10; p<0.001). The external validity of the studies was limited because patients with severe somatic and mental disorders were excluded.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RPT improves behavioural and physiological reactions [59], thus their effects might indirectly affect cognitive reactions (that is, PC).”
From Effectiveness of cognitive behaviour therapy for the treatment of catastrophisation in patients with fibromyalgia: A randomised controlled trial (2011) · cites this paper as [59]
In the citing paper
“Patients with severe somatic comorbidities including inflammatory rheumatic disorders were excluded by all trials.”
From Comparative Efficacy and Harms of Duloxetine, Milnacipran, and Pregabalin in Fibromyalgia Syndrome (2010) · cites this paper as [32]
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04337-3 · Cited by 5,373
Dworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Kerns, R. D., Ader, D. N., et al. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.005 · Cited by 3,471
Updated Method Guidelines for Systematic Reviews in the Cochrane Collaboration Back Review Group
van Tulder, M., Furlan, A., Bombardier, C., & Bouter, L. (2003) · Spine · doi:10.1097/01.brs.0000065484.95996.af · Cited by 2,180
A Fail-Safe N for Effect Size in Meta-Analysis
Orwin, R. G. (1983) · Journal of Educational Statistics · doi:10.2307/1164923 · Cited by 2,064 · cited 1×
“Therefore we did not perform funnel plots [12] and did not calculate fail-safe Ns [27] to check for a potential publication bias.”
MethodMoher, D., Schulz, K. F., Altman, D. G., & for the CONSORT Group* (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00011 · Cited by 1,426
Rules of Evidence and Clinical Recommendations on the Use of Antithrombotic Agents
Sackett, D. L. (1989) · CHEST Journal · doi:10.1378/chest.95.2_supplement.2s · Cited by 1,369
Medically Unexplained Physical Symptoms, Anxiety, and Depression: A Meta-Analytic Review
Henningsen, P., Zimmermann, T., & Sattel, H. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000075977.90337.e7 · Cited by 829
EULAR evidence-based recommendations for the management of fibromyalgia syndrome
Carville, S. F., Arendt-Nielsen, S., Bliddal, H., Blotman, F., Branco, J. C., Buskila, D., Da Silva, J. A. P., Danneskiold-Samsøe, B., Dincer, F., Henriksson, C., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.071522 · Cited by 752
Research works printed but not linked: 1
- Staud, 2008, Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: How study designs can effect placebo factors., Pain, 232-, 234
Cited by
Sorted by citations
Items 101–200 of 242
Pérez‐Aranda, A., Feliu‐Soler, A., Mist, S. D., Jones, K. D., del Hoyo, Y. L., Oliván-Arévalo, R., Kratz, A. L., Williams, D. A., & Luciano, J. V. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18010247 · Cited by 19
Kim, S. C., Landon, J. E., & Lee, Y. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0530-8 · Cited by 19
Fibromyalgia and Fatigue: Central Processing, Widespread Dysfunction
Finan, P., & Zautra, A. (2010) · PM & R : the journal of injury, function, and rehabilitation · doi:10.1016/j.pmrj.2010.03.021 · Cited by 16
Interpreting Effect Sizes and Clinical Relevance of Pharmacological Interventions for Fibromyalgia
Arnold, L. M., Cappelleri, J. C., Clair, A. G., & Masters, E. T. (2013) · Pain and Therapy · doi:10.1007/s40122-013-0011-1 · Cited by 18
Pregabalin reduces cisplatin-induced mechanical allodynia in rats
Seto, Y., Takase, M., Tsuji, Y., & To, H. (2017) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2017.06.003 · Cited by 17
Management of occupation-related musculoskeletal disorders
Jezukaitis, P. T., & Kapur, D. (2011) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2011.01.010 · Cited by 16
Fibromyalgia in Older Individuals
Minerbi, A., & Fitzcharles, M. (2021) · Drugs & Aging · doi:10.1007/s40266-021-00879-x · Cited by 16
Swanenburg, J., Gruber, C., Brunner, F., & Wirth, B. (2014) · Physiotherapy Theory and Practice · doi:10.3109/09593985.2014.994152 · Cited by 16
Noncardiac Chest Pain and Fibromyalgia
Almansa, C., Wang, B., & Achem, S. R. (2010) · Medical Clinics of North America · doi:10.1016/j.mcna.2010.01.002 · Cited by 16
An update on emerging drugs for fibromyalgia treatment
Atzeni, F., Gerardi, M. C., Masala, I. F., Alciati, A., Batticciotto, A., & Sarzi‐Puttini, P. (2017) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2017.1418323 · Cited by 17
Kleinman, N. L., Sanchez, R. J., Lynch, W. D., Cappelleri, J. C., Beren, I. A., & Joshi, A. V. (2011) · Pain Practice · doi:10.1111/j.1533-2500.2011.00453.x · Cited by 15
Mukae, T., Fujita, W., & Ueda, H. (2016) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2016.01.002 · Cited by 15
Illness perceptions and burden of disease in fibromyalgia
Skaer, T. L., & Kwong, W. J. (2016) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2017.1270207 · Cited by 17
Pregabalin for the Treatment of Abdominal Adhesion Pain
Silverman, A. L., Samuels, Q. N., Gikas, H., & Nawras, A. T. (2011) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e318217a5f5 · Cited by 14
Cost-effectiveness Analysis of Pharmacologic Treatment of Fibromyalgia in Mexico
Arreola‐Ornelas, H., Rosado-Buzzo, A. A., Garcı́a, L., Dorantes-Aguilar, J., Contreras-Hernández, I., & Quevedo, J. F. M. (2012) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2011.12.003 · Cited by 14
A capital role for the brain’s insula in the diverse fibromyalgia-associated symptoms
Paepe, B. D., Smet, J., Baeken, C., Oosterwijck, J. V., & Meeus, M. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110077 · Cited by 15
Chen, Y., Wang, E. J., Sites, B. D., & Cohen, S. P. (2023) · Regional Anesthesia & Pain Medicine · doi:10.1136/rapm-2022-104203 · Cited by 13
A Comprehensive Analysis of Fibromyalgia and the Role of the Endogenous Opioid System
García‐Domínguez, M. (2025) · Biomedicines · doi:10.3390/biomedicines13010165 · Cited by 13
Vetter, T. R. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1651-8_11 · Cited by 13
Morris, S. J., Li, Y., Smith, J. A. M., Dubé, S., Burbridge, C., & Symonds, T. L. (2017) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-017-1544-y · Cited by 12
Persistence of pregabalin treatment in Taiwan: a nation-wide population-based study
Wang, Y.-F., Chen, Y., Tsai, C., Yen, Y., Chen, Y., Shia, B., & Wang, S. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01123-4 · Cited by 12
Jamison, R. N., Curran, S., Wan, L., Ross, E. L., Gilligan, C. J., & Edwards, R. R. (2021) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.13463 · Cited by 13
Management of Fibromyalgia in Older Adults
Fitzcharles, M., Ste‐Marie, P. A., Shir, Y., & Lussier, D. (2014) · Drugs & Aging · doi:10.1007/s40266-014-0210-4 · Cited by 11
Gilron, I., Robb, S., Tu, D., Holden, R. R., Milev, R. V., & Towheed, T. (2023) · Pain · doi:10.1097/j.pain.0000000000002875 · Cited by 12
Do fibromyalgia patients use active pain management strategies? A cohort study
Gauffin, J., Hankama, T., Hannonen, P., Kautiainen, H., Pohjolainen, T., & Haanpää, M. L. (2013) · Journal of Rehabilitation Medicine · doi:10.2340/16501977-1133 · Cited by 10
Migliorini, F., Maffulli, N., Eschweiler, J., Tingart, M., Driessen, A., & Colarossi, G. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1929923 · Cited by 10
Outcomes of a Comprehensive Pain Rehabilitation Program for Patients With Fibromyalgia
Engelberg-Cook, E., Hu, D., Kurklinsky, S., Mack, A., Sletten, C. D., Qu, W., & Osborne, M. D. (2021) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2021.08.008 · Cited by 9
Duloxetine: A Review of its Safety and Efficacy in the Management of Fibromyalgia Syndrome
Smith, H. S., Bracken, D., & Smith, J. M. (2010) · Journal of Central Nervous System Disease · doi:10.4137/jcnsd.s4127 · Cited by 12
Pathogenic Role of iNOs+ M1 Effector Macrophages in Fibromyalgia
Tripathi, V., Mishra, A., Pathak, Y., Jain, A., & Prakash, H. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.94492 · Cited by 9
Novel pharmaceutical options for treating fibromyalgia
Gerardi, M. C., Batticciotto, A., Talotta, R., Franco, M. D., Atzeni, F., & Sarzi‐Puttini, P. (2016) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1145052 · Cited by 10
Alpha-2-delta ligands in fibromyalgia: Is the glass half empty or full?
Clauw, D. J. (2009) · Pain · doi:10.1016/j.pain.2009.06.015 · Cited by 9
Kamaly, N. A., Kamel, A. S. E. D., Sadik, N. A. H., & Shahin, N. N. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04723-w · Cited by 8
[Towards a unified treatment approach for functional somatic syndromes and somatization].
Schröder, A., Fink, P., Fjordback, L., Frostholm, L., & Rosendal, M. (2010) · PubMed · Cited by 8
Fibromyalgia Animal Models Using Intermittent Cold and Psychological Stress
Ueda, H., & Neyama, H. (2023) · Biomedicines · doi:10.3390/biomedicines12010056 · Cited by 9
Fibromyalgia and Chronic Fatigue Syndrome: Management Issues
Bourke, J. H. (2015) · Advances in psychosomatic medicine · doi:10.1159/000369087 · Cited by 8
Acute and Chronic Pain Management in Fibromyalgia: Updates on Pharmacotherapy
Hsu, E. S. (2010) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181d6b6d4 · Cited by 10
Gilron, I., Tu, D., Holden, R. R., Towheed, T., Ziegler, D., Wang, L., Milev, R. V., & Gray, C. (2017) · JMIR Research Protocols · doi:10.2196/resprot.7198 · Cited by 8
Análisis de coste-efectividad en el tratamiento farmacológico del síndrome de fibromialgia en México
Arreola‐Ornelas, H., Rosado-Buzzo, A. A., Garcı́a, L., Dorantes-Aguilar, J., Contreras-Hernández, I., & Quevedo, J. F. M. (2012) · Reumatología Clínica · doi:10.1016/j.reuma.2011.12.009 · Cited by 7
Traitements de la douleur en rhumatologie
Vergne‐Salle, P., Beaulieu, P., Coutaux, A., Sichère, P., Perrot, S., & Bertin, P. (2014) · Cited by 7
Pharmacological Approaches to Tinnitus Treatment
Elgoyhen, A. B., & Langguth, B. (2010) · Springer eBooks · doi:10.1007/978-1-60761-145-5_78 · Cited by 7
Antiepileptic Drugs Beyond Epilepsy (Use of Anticonvulsants in the Treatment of Pain Syndromes)*
Давыдов, О. С. (2014) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-014-9982-6 · Cited by 7
The safety of pregabalin in the treatment of fibromyalgia
Gerardi, M. C., Atzeni, F., Batticciotto, A., Franco, M. D., Rizzi, M., & Sarzi‐Puttini, P. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1242575 · Cited by 7
Pharmacological Treatment of Fibromyalgia
Guymer, E. K., & Littlejohn, G. O. (2021) · Springer eBooks · doi:10.1007/978-3-030-78638-0_4 · Cited by 8
Síndrome fibromiálgico: tratamiento multidisciplinario según evidencia
Osorio, M. A. M., Mejía-Mejía, J., & Sanmiguel, E. R. (2010) · Revista Colombiana de Reumatología · doi:10.1016/s0121-8123(10)70070-0 · Cited by 6
Tratamiento farmacológico en la fibromialgia
Redondo, J. R. (2011) · Seminarios de la Fundación Española de Reumatología · doi:10.1016/j.semreu.2010.05.003 · Cited by 6
Estrategias de prescripción de fármacos en el tratamiento de pacientes con fibromialgia
Rivera, J., Vallejo, M. Á., & Esteve-Vives, J. (2012) · Reumatología Clínica · doi:10.1016/j.reuma.2012.02.009 · Cited by 6
Drug Prescription Strategies in the Treatment of Patients With Fibromyalgia
Rivera, J., Vallejo, M. Á., & Esteve-Vives, J. (2012) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2012.06.016 · Cited by 6
Gilron, I., DeBow, C., Elkerdawy, H., Khan, J. S., Salomons, T. V., Duggan, S., Tu, D., Holden, R. R., Milev, R. V., Buckley, D. N., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-087180 · Cited by 6
Women with fibromyalgia syndrome in New Zealand: the symptom experience.
Theadom, A., Cropley, M., Parker, P., & Feigin, V. L. (2011) · PubMed · Cited by 4
Combination pharmacotherapy for the treatment of fibromyalgia
Gilron, I., Shum, B., Moore, A., & Wiffen, P. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010585 · Cited by 5
Smith, H. S., Harris, R. E., & Clauw, D. J. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2242-0.00058-4 · Cited by 5
Späth, M. (2011) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-011-0783-9 · Cited by 5
Fibromyalgie : où en est-on en 2015 ?
Laroche, F., & Guérin, J. (2015) · Douleur et Analgésie · doi:10.1007/s11724-015-0407-2 · Cited by 5
Sleep Disturbances in General Medical Disorders
Chokroverty, S. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6578-6_47 · Cited by 5
Inflammation and pain as interconnected targets in axial spondyloarthritis
Baraliakos, X., Navarro‐Compán, V., Ziadé, N., & Poddubnyy, D. (2026) · Nature Reviews Rheumatology · doi:10.1038/s41584-025-01348-0 · Cited by 4
Transcutaneous Electrical Nerve Stimulation and Pain With Movement in People With Fibromyalgia
Dailey, D. L., Vance, C. G. T., Gorp, B. J. V., Johnson, E. M., Post, A. A., Chimenti, R. L., Vance, K. G., Franck, C., Sault, J. D., Yaraşır, E., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.2450 · Cited by 4
Fibromyalgia in the Context of Rheumatoid Arthritis: A Review
Dolan, L. B., Lld, T., & Raizada, V. (2016) · Cited by 4
Crofford, L. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00052-8 · Cited by 4
Fibromyalgia and Centralized Pain States
Brummett, C. M., & Clauw, D. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40196-8.00026-7 · Cited by 4
Pain-processing mechanisms in whiplash associated disorders
Curatolo, M., & Sterling, M. M. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7295-3946-3.10005-3 · Cited by 4
Quality of Life in Patients with Fibromyalgia
Tawadros, A. E., Udeoji, D. U., Awad, M., de Castro-Abeger, A. H., Nguyen, T., Bensoussan, J.-C., & IsHak, W. W. (2013) · International Journal of Clinical Psychiatry and Mental Health · Cited by 4
(2010) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2010.08.0042 · Cited by 4
Why It Is Important to Consider the Effects of Analgesics on Sleep: A Critical Review
Iacovides, S., Kamerman, P. R., Baker, F. C., & Mitchell, D. (2021) · Comprehensive physiology · doi:10.1002/cphy.c210006 · Cited by 5
Management strategies for fibromyalgia
Littlejohn, G., & Marshakk, L. (2011) · Open Access Rheumatology Research and Reviews · doi:10.2147/oarrr.s10691 · Cited by 3
Fibromyalgia and the old dilemma: Theory vs. practice.
Martinez, J. E. (2014) · Psychology & Neuroscience · doi:10.3922/j.psns.2014.1.03 · Cited by 3
Treatment Recommendations for Fibromyalgia
Skaer, T. L. (2016) · International journal of pharma research and review · Cited by 3
Alves, L. G., Pacheco‐Barrios, K., Lacerda, G. J. M., & Fregni, F. (2025) · NeuroSci · doi:10.3390/neurosci6010015 · Cited by 3
La fibromyalgie est-elle une maladie psychiatrique ?
Fond, G. B., Capdevielle, D., Attal, J., & Boulenger, J.-P. (2011) · PSN · doi:10.1007/s11836-011-0176-9 · Cited by 2
Abordaje integrado de la fibromialgia
Ramírez, F. B., Mas, M. T., Núñez, C. G., Jiménez, N. R., & Caballero, F. L. P. (2017) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2016.12.003 · Cited by 4
Danazumi, M. S., Abubakar, M. F., Ibrahim, S. U., & Yakasai, A. M. (2020) · Advances in Integrative Medicine · doi:10.1016/j.aimed.2020.07.014 · Cited by 2
Laroche, F. (2014) · EMC - Aparato Locomotor · doi:10.1016/s1286-935x(14)67556-0 · Cited by 2
Giraldo, W. A. S., & Hita, J. L. M. (2017) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2017.02.004 · Cited by 2
Anticonvulsants in the Management of Chronic Pain
Finnerup, N. B., Baastrup, C., & Jensen, T. S. (2010) · doi:10.1002/9781444329711.ch15 · Cited by 2
Monigold, M., Philip, S., & Lucashu, A. (2023) · Evidence-Based Practice · doi:10.1097/ebp.0000000000001942 · Cited by 1
Sant-Cassia, M., Lee, C.-H., Tiruveedhula, V. V. N. P. B., Cook, J. M., Chen, C., & Chiou, L. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e00956 · Cited by 1
Fibromyalgia syndrome: Treatment multidisciplinary according to evidence
Osorio, M. A. M., Mejía-Mejía, J., & Sanmiguel, E. R. (2010) · Revista Colombiana de Reumatología · Cited by 1
The Specific Condition: Other Causes of Neuropathic Pain
Toth, C. C., & Moulin, D. E. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139152211.016 · Cited by 1
Tratamientos del dolor en reumatología
Vergne‐Salle, P., Beaulieu, P., Coutaux, A., Sichère, P., Perrot, S., & Bertin, P. (2015) · EMC - Aparato Locomotor · doi:10.1016/s1286-935x(15)70088-2 · Cited by 1
Le syndrome fibromyalgique : stratégies thérapeutiques
Sichère, P. (2013) · Douleurs Évaluation - Diagnostic - Traitement · doi:10.1016/j.douler.2013.10.006 · Cited by 1
Diagnosis and Management of Fibromyalgia: How and Why
Hayhoe, S. (2011) · Pain Management · doi:10.2217/pmt.11.19 · Cited by 1
Häuser, W. (2011) · Springer eBooks · doi:10.1007/978-3-642-12819-6_28 · Cited by 1
Self-citationDomínguez-Muñoz, A., Carlos‐Vivas, J., Pastor-Cisneros, R., Rojo-Ramos, J., My works are correct, B. M. I. A. A. I. S. R. L. M. T. I. D. A.-M., & Domínguez‐Muñoz, F. J. (2021) · e-Motion Revista de Educación Motricidad e Investigación · doi:10.33776/remo.vi17.5408 · Cited by 1
Chronic Neuropathic Pain: Fibromyalgia
Miedany, Y. M. E. (2022) · Contemporary rheumatology · doi:10.1007/978-3-031-10687-3_11 · Cited by 1
Leenus, A., Rahman, R., Dana, E., Tran, C., Westwood, D. J., Osokin, E. E., Hoydonckx, Y., Moayedi, M., Hirani, S., & Khan, J. S. (2025) · Pain Management · doi:10.1080/17581869.2025.2459594 · Cited by 1
Treatment of Special Groups: Children, Pregnant, Elderly, and Mentally Disabled
Mathur, S., & James, D. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-15820-4_10 · Cited by 1
Targeting fibromyalgia pain: brain–spinal cord and peripheral contributions
Franklyn, K., Guymer, E. K., & Littlejohn, G. O. (2011) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.11.41 · Cited by 1
Fibrofascitis – An Enigma for the Dentist: A Case Report
Shrivastava, K. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/17130.7575 · Cited by 1
Fibromiyalji Sendromunda D Vitamin Düzeylerinin Değerlendirilmesi
Özgen, M., Çıracıoğlu, A. M., Uygur, A., Armağan, O., Berkan, F., & Mutlu, F. (2018) · OSMANGAZİ JOURNAL OF MEDICINE · doi:10.20515/otd.459018 · Cited by 1
Modern approaches to the treatment of fibromyalgia
Nasonova, T. I., Mukhametzyanova, A. K., Tabeyeva, G. R., & Chernousov, P. A. (2021) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2021-5-83-89 · Cited by 1
Evaluación de la función sexual en mujeres y hombres con fibromialgia
Rico‐Villademoros, F. (2014) · Institutional Repository of the University of Granada (University of Granada) · Cited by 1
Fontenele, J. B., & Felix, F. H. C. (2011) · Rheumatology International · doi:10.1007/s00296-011-2255-6 · Cited by 1
Amris, K. (2014) · doi:10.2217/fmeb2013.13.160 · Cited by 1
(2018) · Elsevier eBooks · doi:10.1016/b978-3-437-23672-3.00005-6 · Cited by 1
UTILIZING THE STANDARD TRAUMA-FOCUSED EMDR PROTOCOL IN TREATMENT OF FIBROMYALGIA
Teneycke, T. L. (2012) · OhioLink ETD Center (Ohio Library and Information Network) · doi:10.13140/2.1.3597.6007
Treatment and Therapeutic Perspectives
Algret, C., Pimont, M., & Beaulieu, P. (2014) · Springer eBooks · doi:10.1007/978-2-8178-0414-9_15
Fibromyalgia Syndrome and Myofascial Pain Syndromes
Häuser, W., Schiltenwolf, M., & Henningsen, P. (2010) · Wiley eBooks · doi:10.1002/9781444329711.ch28
Self-citationCHRONIC OPIOID USE IN FIBROMYALGIA SYNDROME: CHARACTERISTICS AND OUTCOMES
Painter, J. T. (2012) · UKnowledge (University of Kentucky)
Smith, H. S., Pappagallo, M., & Stahl, S. M. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139194464.047
Sick and tired: understanding and managing sleep difficulties in Fibromyalgia Syndrome
Theadom, A. (2011) · Tuwhera (Auckland University of Technology)
Metadata
- Authors
- Häuser, W., Bernardy, K., Üçeyler, N., & Sommer, C.
- Affiliations
- Klinikum Saarbrücken (DE)
- Saarland University (DE)
- University of Würzburg (DE)
- Corresponding author
- Häuser, Winfried
- Venue
- Pain
- Published
- 2009-09
- Volume
- 145
- Issue
- 1
- Pages
- 69-81
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2023541450
- Cited by
- 243
- References
- 43
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 4 · 2023: 5 · 2022: 8 · 2021: 13 · 2020: 9 · 2019: 7 · 2018: 10 · 2017: 13 · 2016: 16 · 2015: 14 · 2014: 15 · 2013: 23 · 2012: 24
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pain (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Funders
- Eli Lilly and Company
- Pfizer
- Cilag
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Keywords
- fibromyalgia, gabapentin, pregabalin, analgesia, sleep quality, health-related quality of life, fatigue, anxiety, depressive mood, antiepileptic drugs
- MeSH terms
- Pregabalin, Gabapentin, Amines, Analgesics, Calcium Channel Blockers, Cyclohexanecarboxylic Acids, Fibromyalgia, gamma-Aminobutyric Acid, Humans, Reproducibility of Results, Randomized Controlled Trials as Topic, Databases, Bibliographic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review